# Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma

> **NCT01580969** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 22 (actual)

## Conditions studied

- Recurrent Glioma

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Minocycline
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT01580969
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-06
- **Primary completion:** 2018-01-12
- **Final completion:** 2018-05-15
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580969, "Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01580969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*